NPPA and obesity due to melanocortin 4 receptor deficiency: Lower systemic vascular resistance, plasma renin activity and renin-angiotensin responses, lower levels of atrial natriuretic peptides, and an attenuated sympathetic nervous system are pathophysiological changes in obese patients that can balance the risk that obesity itself represents [27].